TICKERNERD
Menu
NNOXNNOXHealthcare · Medical Devices

NNOX Stock Forecast: Nano-X Imaging Ltd. Price Predictions for 2026-2027

Last close, 21 Aug 2026
$0.86
−2.84% on the day

The 3 Wall Street analysts covering Nano-X Imaging Ltd. hold a median 12-month price target of $5 — +481.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 27 of 100 as at 22 Aug 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$67.6M
Ticker Nerd rank
27 / 100
Median analyst target
$5.00
Analysts covering
3
Total return, dividends reinvested
1W
−13.8%
1M
−20.4%
YTD
−69.3%
1Y
−78.6%
From 52W high
−81.1%
From 52W low
0.0%
$0.86
$4.55
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

NNOX stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Nano-X Imaging Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
27 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
90
Size
80
Revisions
71
Growth
40
Issuance
33
Volatility
19
Quality
9
Value
7
Momentum
5

Accruals (90): Reported profit is backed by cash, and the company is not expanding recklessly.

Momentum (5): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

NNOX stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on NNOX, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.00$2.00$4.00$6.00$8.00Oct 25Jan 26Apr 26Jul 26NNOXHigh $7.40Median $5.00Low $3.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says3 analysts
2 Buy1 Hold0 Sell
Low $3.00Median $5.00High $7.40

The green dot is the last close — the median target sits +481.5% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
17 Aug 2026Cantor FitzgeraldReiteratesOverweight$5.00
7 July 2026Alliance Global PartnersDowngradeNeutral$5.00 → $3.00
7 July 2026Alliance Global PartnersDowngradeNeutral—
20 Apr 2026D. Boral CapitalMaintainsBuy—
13 Apr 2026D. Boral CapitalMaintainsBuy—
3 Mar 2026D. Boral CapitalMaintainsBuy—
4 Feb 2026D. Boral CapitalMaintainsBuy—
20 Nov 2025D. Boral CapitalMaintainsBuy—
18 Nov 2025D. Boral CapitalMaintainsBuy—
19 Sept 2025D. Boral CapitalMaintainsBuy—
13 Aug 2025D. Boral CapitalMaintainsBuy—
6 June 2025D. Boral CapitalMaintainsBuy—
23 May 2025D. Boral CapitalMaintainsBuy—
17 Apr 2025D. Boral CapitalMaintainsBuy—
1 Apr 2025Cantor FitzgeraldMaintainsOverweight—
31 Mar 2025D. Boral CapitalMaintainsBuy—
25 Feb 2025D. Boral CapitalMaintainsBuy—
6 Jan 2025D. Boral CapitalInitiatesBuy—
6 Dec 2024Cantor FitzgeraldMaintainsOverweight—
26 Nov 2024Cantor FitzgeraldMaintainsOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NNOX appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

NNOX analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
1
Analysts cutting
0
Fundamentals

Nano-X Imaging Ltd. (NNOX) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−0.7×

Cheaper than 81% of US stocks

Price / sales
4.7×

Cheaper than 26% of US stocks

Price / book
0.5×

Cheaper than 85% of US stocks

EV / EBITDA
−0.5×

Cheaper than 64% of US stocks

Growth & margins
Revenue growth (YoY)
53.1%

Higher than 87% of US stocks

Earnings growth (YoY)
53.1%

Higher than 76% of US stocks

Gross margin
−60.0%

Higher than 2% of US stocks

Operating margin
−337.0%

Higher than 9% of US stocks

Net margin
−98.2%

Higher than 6% of US stocks

Returns & dividend
Return on equity
−50.1%

Higher than 21% of US stocks

Return on assets
−22.3%

Higher than 18% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

NNOX vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
NNOXNano-X Imaging Ltd.$67.6M
27
MYOMyomo, Inc.$68.5M
45
CVRXCVRx, Inc.$74.7M
34
OMOutset Medical, Inc.$77.0M
29
COCHEnvoy Medical, Inc.$57.7M
34
SRTSSensus Healthcare, Inc.$54.9M
45
RPIDRapid Micro Biosystems, Inc.$83.7M
32

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Nano-X Imaging Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest NNOX news & analysis

Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom

GlobeNewsWire · 18 Aug 2026positive

Nanox Imaging announced that its subsidiary, Nanox AI Ltd., entered an exclusive sales reseller agreement with Vertec Scientific for the commercialization of the Nanox.AI Bone Solution (HealthOST) in the United Kingdom. The initial three-year term includes minimum annual license commitments.

Why it matters — This expands NNOX's distribution of its AI bone-scanning product into the UK market with guaranteed minimum license commitments over a three-year term.

Urgent Deadline for Shareholders who lost money in shares of Nano-X Imaging Ltd. (NASDAQ: NNOX)

PRNewsWire · 11 Aug 2026negative

Wolf Haldenstein Adler Freeman & Herz LLP reminded Nano-X Imaging Ltd. investors that August 11, 2026 is the lead plaintiff deadline in a securities class action. The lawsuit covers stockholders who bought Nano-X securities between March 31, 2025 and April 17, 2026.

Why it matters — NNOX watchers should be aware that a securities class action has been filed against the company covering a defined class period, with a lead plaintiff deadline now approaching.

Nano-X Deadline: NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud Lawsuit

PRNewsWire · 9 Aug 2026negative

Rosen Law Firm reminded purchasers of Nano-X Imaging Ltd. (NASDAQ: NNOX) securities between March 31, 2025 and April 17, 2026 of the August 11, 2026 lead plaintiff deadline in a securities fraud lawsuit. The deadline applies to those who purchased during the Class Period.

Why it matters — NNOX watchers would care because the item signals an active securities fraud lawsuit against the company and an approaching deadline for affected investors to participate.

FAQ

Frequently asked questions about NNOX stock

What is the NNOX stock price forecast for 2026-2027?

The 3 Wall Street analysts covering Nano-X Imaging Ltd. have a median 12-month price target of $5, with estimates ranging from $3 to $7.4. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is NNOX stock a buy right now?

Of the 3 analysts covering Nano-X Imaging Ltd., 2 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Nano-X Imaging Ltd. 27 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank NNOX?

As at 22 Aug 2026, Nano-X Imaging Ltd. ranks 27 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (90 of 100).

Will NNOX stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +481.5% from the last close, and Ticker Nerd's factor model ranks Nano-X Imaging Ltd. 27 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the NNOX stock forecast for 2030?

No analyst covering Nano-X Imaging Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NNOX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $3 to $7.4 over the next 12 months.

How has NNOX stock performed over the past year?

Nano-X Imaging Ltd. returned -78.6% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Nano-X Imaging Ltd. do?

Nano-X Imaging Ltd. is a medical imaging company known for its innovative approach to diagnostic technologies.

What is the latest news on NNOX?

The most recent item we track (GlobeNewsWire, 18 Aug 2026): "Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom". Nanox Imaging announced that its subsidiary, Nanox AI Ltd., entered an exclusive sales reseller agreement with Vertec Scientific for the commercialization of the Nanox.AI Bone Solution (HealthOST) in the United Kingdom. The initial three-year term includes minimum annual license commitments.

Company

About Nano-X Imaging Ltd.

Nano-X Imaging Ltd. is a medical imaging company known for its innovative approach to diagnostic technologies. It focuses on developing and commercializing novel X-ray systems designed to improve access to medical imaging and enhance healthcare delivery worldwide. A significant feature of Nano-X Imaging's technology is the "Nanox.ARC," a digital X-ray system that aims to integrate next-generation imaging capabilities with artificial intelligence to facilitate early disease detection. This system is complemented by the "Nanox.CLOUD," a cloud-based software platform intended to provide imaging analytics and management tools to healthcare providers. The company's efforts are geared towards addressing the limitations of traditional radiography solutions, such as high costs and complex infrastructure needs. By making advanced imaging more accessible and affordable, Nano-X Imaging Ltd. could play a pivotal role in transforming medical diagnostics, particularly in underserved regions, contributing significantly to global health initiatives and the medical devices sector.

CEO Mr. Erez I. Meltzer · 197 employees · Israel · https://www.nanox.vision